This Week's Headlines: March 15, 2021
This week, people with asthma not at higher risk for poor COVID-19 outcomes; adherence to asthma biologic therapy higher than inhaled corticosteroids; health care affordability, racial disparities persist in individuals with asthma, COPD; and more.
Read Healio's full coverage here:
People with asthma not at higher risk for poor COVID-19 outcomes, study finds
Adherence to asthma biologic therapy higher than inhaled corticosteroids
Health care affordability, racial disparities persist in individuals with asthma, COPD
Study supports early discharge, ambulatory rivaroxaban in low-risk pulmonary embolism
Low-risk status achieved or maintained in minority of patients on PAH combination therapy
References:
Badagliacca R, et al. Am J Respir Crit Care Med. 2021;doi:10.1164/rccm.202004-1006OC.
Barco S, et al. Eur Respir J. 2021;doi:10.1183/13993003.02368-2020.
Gaffney AW, et al. Chest. 2021;doi:10.1016/j.chest.2021.01.035.
Maddux JT, et al. Chest. 2020;doi:10.1016/j.chest.2020.10.050.
Sunjaya AP, et al. J Asthma. 2021;doi:10.1080/02770903.2021.1888116.
Collapse
Read more about
